| abstract |
The invention relates to a thrombopoietin polypeptide which exhibits activity of stimulating or increasing the production of platelets in vivo or enhancing the proliferation and differentiation of megakaryocyte cells, to the DNA sequence encoding it, to a process for the preparation of the thrombopoietin polypeptide and to a pharmaceutical composition with this thrombopoietin polypeptide, which is administered in the treatment of platelets dysfunction. |